O I Urazova Selected Research

Pulmonary Tuberculosis

11/2019	Effects of Levofloxacin on Blood Lymphocyte Apoptosis in Patients with Pulmonary Tuberculosis: an In Vitro Study.
1/2019	Association between polymorphisms of cytokine genes and secretion of IL-12p70, IL-18, and IL-27 by dendritic cells in patients with pulmonary tuberculosis.
12/2018	In Vitro Study of the Modulatory Effects of Levofloxacin and BCG on Secretion of Proinflammatory Cytokines in Infiltrative Pulmonary Tuberculosis.
7/2018	Subpopulation Structure of IFNγ-Producing T Lymphocytes in Patients with Pulmonary Tuberculosis.
7/2015	Molecular Factors of Cytokine-Dependent Activation of T Cells in Pulmonary Tuberculosis.
7/2015	Factors of Suppression of Immune Response in Patients with Pulmonary Tuberculosis and Eosinophilia.
6/2015	Factors of Th17 and Treg Lymphocyte Differentiation in Pulmonary Tuberculosis.
1/2015	[Expression of mRNA transcription factors RORC2 and FoxP3 in lymphocytes in patients with pulmonary tuberculosis].
4/2014	Functional activity of Th-17 lymphocytes in pulmonary tuberculosis.
7/2012	Cytokine-secreting activity of blood eosinophils in pulmonary tuberculosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

O I Urazova Research Topics

Disease

23	Pulmonary Tuberculosis 11/2019 - 01/2005
9	Tuberculosis (Tuberculoses) 11/2019 - 01/2005
5	Infections 01/2015 - 04/2009
4	Hemolysis 01/2013 - 10/2011
3	Eosinophilia 06/2018 - 01/2012
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2013 - 01/2012
2	Wounds and Injuries (Trauma) 01/2012 - 10/2011
2	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2010 - 09/2008
2	Infectious Mononucleosis (Glandular Fever) 01/2003 - 01/2002
1	Colorectal Neoplasms (Colorectal Cancer) 06/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2018
1	Neoplasms (Cancer) 06/2018
1	Parasitic Diseases (Parasitic Disease) 04/2015
1	Communicable Diseases (Infectious Diseases) 01/2015
1	hereditary Thrombophilia 01/2013
1	Chronic Renal Insufficiency 01/2013
1	Antithrombin III Deficiency 01/2013
1	Thrombophilia 01/2013
1	Diabetes Mellitus 08/2012
1	Diabetic Nephropathies (Diabetic Nephropathy) 08/2012
1	Inflammation (Inflammations) 01/2012
1	Herpesviridae Infections (Herpesvirus Infection) 07/2009
1	Goiter 09/2008
1	Thyroiditis 09/2008
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2006
1	Pneumonia (Pneumonitis) 01/2005
1	Convalescence 12/2002

Drug/Important Bio-Agent (IBA)

14	CytokinesIBA 01/2019 - 01/2005
12	Pharmaceutical PreparationsIBA 11/2019 - 01/2005
6	Interleukin-2 (IL2)IBA 07/2012 - 01/2005
3	Interleukin-12 (IL 12)IBA 12/2018 - 01/2009
3	Free RadicalsIBA 01/2012 - 01/2010
3	Isoniazid (Ftivazide)FDA LinkGeneric 01/2010 - 01/2008
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2010 - 01/2008
2	Levofloxacin (Levaquin)FDA Link 11/2019 - 12/2018
2	AntigensIBA 07/2015 - 01/2010
2	Endothelin-1 (Endothelin 1)IBA 01/2013 - 08/2012
2	Complement System Proteins (Complement)IBA 01/2013 - 10/2011
2	von Willebrand FactorIBA 01/2013 - 08/2012
2	Interleukin-5 (Interleukin 5)IBA 07/2012 - 01/2012
2	Hemoglobins (Hemoglobin)IBA 01/2012 - 10/2011
2	Oxygen (Dioxygen)IBA 10/2011 - 01/2006
2	Interleukin-4 (Interleukin 4)IBA 08/2009 - 07/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006 - 01/2005
1	SuspensionsIBA 11/2019
1	Interleukin-18 (Interleukin 18)IBA 01/2019
1	Interleukin-27 (Interleukin 27)IBA 01/2019
1	FluoroquinolonesIBA 12/2018
1	Galectin 3 (LGALS3)IBA 06/2018
1	Galectin 1 (LGALS1)IBA 06/2018
1	Interleukin-6 (Interleukin 6)IBA 06/2015
1	Factor XII (Hageman Factor)IBA 04/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Interleukin-17 (Interleukin 17)IBA 04/2014
1	Interleukin-22 (IL-22)IBA 04/2014
1	AnticoagulantsIBA 01/2013
1	Factor VII (Proconvertin)IBA 01/2013
1	Hemostatics (Antihemorrhagics)IBA 01/2013
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2013
1	PlasminogenIBA 01/2013
1	Prothrombin (Factor II)IBA 01/2013
1	Blood Substitutes (Artificial Blood)IBA 01/2013
1	SympatholyticsIBA 01/2013
1	Angiotensin IIIBA 01/2013
1	eprosartan (Teveten)FDA Link 01/2013
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2013
1	Factor V (Coagulation Factor V)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 08/2012
1	Tuberculin (PPD)IBA 04/2012
1	ChemokinesIBA 01/2012
1	CholesterolIBA 01/2012
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2012
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2010
1	Biological ProductsIBA 04/2009
1	Interleukin-10 (Interleukin 10)IBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 01/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2009
1	MitogensIBA 09/2008
1	EnzymesIBA 01/2008
1	InterferonsIBA 01/2006
1	DNA (Deoxyribonucleic Acid)IBA 01/2005
1	Aligeron (AS 2)IBA 01/2005
1	Oxidoreductases (Dehydrogenase)IBA 01/2003
1	LipopolysaccharidesIBA 12/2002
1	Nucleic AcidsIBA 01/2002
1	RNA (Ribonucleic Acid)IBA 01/2002

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 04/2009 - 01/2005
3	Therapeutics 07/2015 - 01/2006
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2013 - 10/2011
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2013 - 01/2013
1	Aftercare (After-Treatment) 01/2013
1	Immunotherapy 04/2009